Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
William E. Luginbuhl, MD

William E. Luginbuhl, MD Physician

Medical Director, Hematology/Oncology, Chester County Hospital Penn Medicine Clinician of Medicine

Dr. Luginbuhl is employed by Penn Medicine.

About Dr. William E. Luginbuhl

Recognized by Main Line Today's Top Doctor's 2016 issue

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Medical Oncology, 1993

Clinical Expertise:

  • Adjuvant Chemotherapy
  • Adverse Effects to Anticoagulants
  • Amyloidosis
  • Anal Cancer
  • Anaplastic Large Cell Lymphoma
  • Anemia
  • Anemia and Bone Marrow Disorders
  • Anemia of Chronic Disease
  • Anemia of Pregnancy
  • Anticoagulation
  • Antiphospholipid Syndrome
  • Antithrombin Deficiency
  • Autoimmune Hemolytic Anemia
  • B12 Deficiency Anemia
  • Bile Duct Cancer (Cholangiocarcinoma)
  • Biological Targeted Therapy
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Cancer
  • Blood Clot
  • Blood Clotting Disorders (Blood Coagulation)
  • Blood Disorders
  • Blood Platelet Disorders
  • Bone Marrow Biopsy
  • Bone Marrow Disorders
  • Cancer Chemotherapy
  • Cancer Pain
  • Cancer Survivor
  • Carcinoid Tumors
  • Carcinoma In Situ of Breast
  • Carcinoma of Unknown Primary
  • Cervical Cancer
  • Chemoradiation
  • Chronic Lymphocytic Leukemia
  • Chronic Myelocytic Leukemia
  • Clinical Trials
  • Coagulation Disorders
  • Cold Agglutinin Disease
  • Colon Tumors
  • Colorectal Cancer
  • Cryoglobulinemia
  • Cutaneous Lymphoma
  • Deep Thrombophlebitis
  • Deep Vein Thrombosis
  • Dyskeratosis Congenita
  • Endometrial Cancer
  • Eosinophilic Granuloma
  • Esophageal Cancer
  • Essential Thrombocytosis
  • Factor V Leiden
  • Fallopian Tube Cancer
  • Folic Acid Deficiency
  • Gallbladder Cancer
  • Gastrointestinal Cancer
  • Gastrointestinal Stromal Tumors (GIST)
  • Gestational Trophoblastic Disease
  • Hairy Cell Leukemia
  • Head and Neck Tumor
  • Hematologic Malignancies
  • Hemochromatosis
  • Hemolytic Anemia
  • Heparin-Induced Thrombocytopenia
  • Hodgkin Lymphoma
  • Hypercoagulable State
  • Hypogammaglobulinemia
  • Idiopathic Thrombocytopenic Purpura
  • Immunotherapy
  • Iron Deficiency Anemia
  • Iron Metabolism Disorders
  • Kidney Cancer
  • Laryngeal Cancer
  • Leukemia
  • Leukocytosis
  • Leukopenia
  • Light Chain Disorders
  • Liver Cancer
  • Lung Cancer
  • Lupus Anticoagulant
  • Lymphoma
  • Lymphopenia
  • Male Breast Cancer
  • Malignant Neoplasm of the Ureter
  • Marginal Zone Lymphoma
  • Maternal Anticoagulation
  • Maternal Hematologic Disorders
  • Maternal Thrombophilia
  • Mediastinal Lymphoma
  • Melanoma
  • Merkel Cell Carcinoma
  • Mesothelioma
  • Monoclonal Gammopathy of Undetermined Significance
  • Mouth Cancer (Oral Cancer)
  • Mucosa-Associated Lymphoid Tissue Lymphoma
  • Multiple Myeloma
  • Musculoskeletal Tumor
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Neoadjuvant Chemotherapy
  • Neuroendocrine Tumors
  • Neutropenia
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Paroxysmal Nocturnal Hemoglobinuria
  • Partial Thromboplastin Time Blood Test
  • Penile Cancer
  • Peripheral T-Cell Lymphoma
  • Pernicious Anemia
  • Petechiae
  • Pituitary Cancer
  • Plasma Cell Dyscrasia
  • POEMS Syndrome
  • Polycythemia
  • Postthrombotic Syndrome
  • Primary Myelofibrosis
  • Primary Systemic Amyloidosis
  • Prolymphocytic Leukemia
  • Prostate Cancer
  • Protein C Deficiency
  • Protein S Deficiency
  • Prothrombin Gene Mutation
  • Pulmonary Metastases
  • Pure Red Cell Aplasia
  • Purpura
  • Rectal Cancer
  • Recurrent Thrombosis
  • Red Blood Cell Disorders
  • Refractory Anemia With Excess Blasts
  • Retroperitoneal Mass
  • Secondary Polycythemia
  • Sezary Syndrome
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Splenic Sequestration
  • Splenomegaly
  • Squamous Cell Carcinoma of the Head and Neck
  • Stomach Cancer (Gastric Cancer)
  • Testicular Cancer
  • Thalassemias
  • Thoracic Cancer
  • Throat Cancer
  • Thrombocytopenia
  • Thrombocytosis
  • Thrombophilia
  • Thrombotic Disorders
  • Thrombotic Thrombocytopenic Purpura
  • Transformed Lymphoma
  • Transitional Cell Carcinoma
  • Urethral Cancer
  • Uterine Cancer
  • Venous-Occlusive Crisis
  • Von Willebrand Disease
  • Waldenstrom Macroglobulinemia (WM)
  • White Blood Cell Disorders
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Vermont
Residency: University of Florida Health System - Shands
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Physicians, National American Society of Clinical Oncology, National

Hospital Affiliation

Dr. Luginbuhl is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.

Research

Selected Publications:

Schuchter, LM, Luginbuhl, WE, Meropol, NJ: The Current status of toxicity protectants in cancer therapy. Semin in Onc 6 (19): 742-51,1992.

Kahn, KJ, Luginbuhl, WE, Gaines, L, Bratschi, J, Bravaria, J, Kaiser, L, Treat, J: Leukocytosis associated with all trans-retinoic acid therapy in metastatic non-small cell lung cancer. JNCI 21 (4:84): 1669-71,1992.

Luginbuhl, WE, Tester, W., Shaw, L, MacDermott, M, Fisherman, J, Spiritos, M., Schuchter, L.: One of two doses of WR-2721, Does it protect patients receiving carboplatin? ASCO : 1992.

Academic Contact Info

Penn Hematology/Oncology
Suite 201
440 East Marshall Street

West Chester, PA 19380
Phone: (610) 738-2500
Patient appointments: 800-789-7366 (PENN)